Navigation Links
Relapse in Risk Management System Claims the Life of Robertson

This report mainly brings to the notice of the common man that how official failings led to a man being bludgeoned to death by a psychiatric patient// with a history of violence. Stuart Robertson was killed by James Smith, who was on conditional discharge from Leverndale Hospital in Glasgow, in October 2004. This report mainly gives us an insight of how there was no systematic approach to risk assessment.

There was a failure to respond adequately to clear signs that Smith's mental illness had relapsed while he was in the care of community-based mental health services. This report was by the Mental Welfare Commission for Scotland. It asks for a series of changes to be implemented by the Scottish Executive, NHS Greater Glasgow and social work chiefs in Glasgow. Smith, 46, had suffered mental problems since 1991. He was jailed for life in Glasgow in November after he admitted the homicide of Mr Robertson.

He had killed Mr Robertson, who also had a history of mental illness, by bludgeoning him to death with a hammer in Pollok Park, Glasgow. The report said that Smith's condition had relapsed in the summer of 2004 but there was no systematic approach to risk assessment in his care and supervision, and an inadequate focus by some of those involved in his care. There was no satisfactory strategy planned to deal with any relapse in his illness.

In the months before the killing he showed signs of relapse but was not recalled to hospital. The Executive, NHS Greater Glasgow and Glasgow City Council acknowledged it had identified weaknesses as the basic risk management was not proper. The deputy health minister, Lewis Macdonald, said that all steps to address the deficiencies identified are being done and the public need not worry about it.


'"/>




Page: 1

Related medicine news :

1. Medications to Prevent Relapse to Cocaine Use
2. Alcoholism Drug Fails To Prevent Drinking Relapses
3. Treatment For Prostate Cancer Relapse Linked To Marital Status
4. New Drug More Effective than Tamoxifen in Preventing Breast Cancer Relapse
5. Femara: The Wonder Drug to Prevent Relapse of Breast Cancer.
6. Rogue Mammary Stem Cells Could Hold Key To Breast Cancer Relapse
7. Hepatitis B Relapse In Cancer Chemotherapy Can Be Avoided By Antiviral Drug
8. Leftover Cancer Cells May Dictate Breast Cancer Relapse
9. Kids are More Prone to Tonsillitis Relapse
10. Colon Cancer Relapse Mainly Caused by Stem Cells
11. ALL Relapses in Most Children After Treatment
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/7/2016)... ... December 07, 2016 , ... A quote from Dr. Edward Hallowell, host ... social media that offer a rare glimpse into the mind of those people with ... York Times bestselling author, has described people with ADHD as having “Ferrari engines for ...
(Date:12/7/2016)... ... December 07, 2016 , ... The ... offices located in South Lyon, Dewitt, Williamston, East Lansing, Ann Arbor, and Farmington ... needs treatment for a brain tumor. , Jason Bauer and his family are ...
(Date:12/7/2016)... ... , ... A. Kevin Spann Insurance, a New York-based firm offering insurance and ... a charity drive to raise funds that will benefit the Marine Corps League. , ... Navy FMF Corpsmen. Working closely with the MCL, the A. Kevin Spann team plans ...
(Date:12/7/2016)... ... 07, 2016 , ... Delete® - Tattoo Removal and Laser Salon Offers Delightful ... Save Up To 33% Off Botox® and Juvederm® Products Now Through December 31, 2016 ... Delightful Deals on Botox® and Juvederm® just in time for the holiday ...
(Date:12/7/2016)... ... December 07, 2016 , ... Gensuite is honored to be ... Best New Product Launch category. Gensuite’s entry on their EZ Scan feature detailed ... Events & Training Group is a professional event and training provider based in ...
Breaking Medicine News(10 mins):
(Date:12/7/2016)... NORTH READING, Mass. , Dec. 7, 2016 ... Track and Trace Network for connecting the Life ... from the global marketplace, today announced that Tjoapack ... 50+ European pharmaceutical manufacturing customers comply with the ... Supply Chain Security Act (DSCSA) in 2017 and ...
(Date:12/7/2016)... According to a new market research report "Clinical Decision Support Systems Market ... Type (Therapeutic, Diagnostic), User Interactivity (Active, Passive), Application - Forecasts to 2021" ... Million by 2021 from USD 856.3 Million in 2016, at a CAGR ... ... MarketsandMarkets Logo ...
(Date:12/7/2016)... 7, 2016 Today, Stock-Callers.com presents four ... JAZZ ), Anthera Pharmaceuticals Inc. (NASDAQ: ANTH ... AveXis Inc. (NASDAQ: AVXS ). From its peak ... 37% to reach a level equal to what it saw ... approximately 14% for the year, it has still out-performed other ...
Breaking Medicine Technology: